Navigation Links
A new way of looking at molecular motors

An innovative method of categorizing myosin--one of three molecular "motors" that produce movement within the cells of the body--has dramatically increased the amount of information available about these essential proteins, laying groundwork for development of treatments for conditions ranging from certain kinds of blindness and kidney disease to neurodegenerative disorders and parasitic diseases such as malaria.

All complex organisms use myosin and its relatives, kinesin and dynein, to move substances around inside cells and to help cells move from one place to the other. Myosins also help parasites enter and infect hosts. Defects in the motors play a role in a variety of human and animal disorders, including retinitis pigmentosa (which causes blindness), polycystic kidney disease, brain development defects, neurodegenerative diseases, muscular dystrophy, skin pigmentation problems, and genetic hearing loss.

Researchers led by Dominique Soldati, a Howard Hughes Medical Institute (HHMI) international research scholar at the University of Geneva in Switzerland, have developed a new system of classifying myosins. Up to now, researchers have only studied approximately 130 myosins at a time. The new system includes 250 myosins and increases the number of myosin subclasses from 18 to 24, enabling researchers to better understand each myosin's function.

"Myosins that belong to the same class work in similar ways but can have very different functions," explained Soldati. "We will have to discover the myosins' functions one by one, and the better we understand how they are related, the faster that will occur."

The new classification system also describes common evolutionary links between subclasses and protein components within myosins themselves. It includes myosins from insects, algae, parasites, and animals that have not been studied before.

The work will appear in the Proceedings of the National Academy of Sciences, with adva nce online publication February 6, 2006. Bernardo Foth, a postdoctoral fellow in Soldati's laboratory, is the first author.

Soldati and Foth became interested in myosins after they discovered that the molecular motors enabled toxoplasmosis and malaria parasites to force their way into human cells.

The researchers say that although their research is theoretical and a long way from clinical applications, the new classification system will help other researchers address important biomedical puzzles more precisely.

"We hope our work will help scientists ask the right questions and perform the right kind of experiments on myosins," Foth said. "In the long term, that could lead to new drug targets being discovered more quickly."

Molecular motors run on tracks, like trains, using chemical reactions that involve the chemical compound adenosine triphosphate (ATP) for fuel. Myosin runs on the filaments of actin, a protein found in muscle cells, but kinesins and dyneins use microtubules, which are hollow protein structures inside the cell, as their track.

Movement is created several ways. Biological cargo is transported within cells by single motors that run backward and forward, the way a person moves hand over hand along a rope. Making muscles contract involves a large number of motors that work very fast in neatly arranged teams, quickly letting go of the track once they have completed their "power stroke."

Most molecular motors have a head, a neck (which powers movement), and a tail. Myosins usually look like two-headed snakes, kinesins like hairpins with a head at each end, and dyneins like three-headed flowers with one stem. Soldati and Foth have confirmed that the motor neck and tail evolved together. That finding helped them define some of their new categories.

Organisms employ all three types of motors at the same time, but in different proportions. For example, yeast uses six kinesins, five myosins, and one dynein while mammals have genes for more than 40 kinesins, 40 myosins and more than a dozen dyneins.

Genetic and acquired defects in the motors cause disease by preventing developing cells from migrating to their necessary destinations before birth or by preventing parts of the body, such as sperm tails or the tiny hairs that keep mucus flowing in the lungs, from moving when they are supposed to. The motors in parasitic organisms contribute to disease by enabling the parasites to break through biological barriers within the human body and actively invade cells.

So far, molecular motors have been found in all organisms but bacteria, red algae, and the parasite Giardia. The new myosin classification system should help cell biologists, biochemists, biophysicists, parasitologists, and medical researchers make advances in a wide variety of fields, from veterinary medicine to tropical diseases.


'"/>

Source:Howard Hughes Medical Institute


Related biology news :

1. Cooperation is key—a new way of looking at MicroRNA and how it controls gene expression
2. Scientists ID molecular switch in liver that triggers harmful effects of saturated and trans fats
3. Source of molecular triggers in cutaneous T cell lymphoma identified
4. Plants, animals share molecular growth mechanisms
5. NYU researchers simulate molecular biological clock
6. Scientists reveal molecular secrets of the malaria parasite
7. Scientists identify molecular events that drive cell senescence
8. Researchers discover molecular mechanism that desensitizes us to cold
9. Findings have implications for tracking disease, drugs at the molecular level
10. Successful Test Of Single Molecule Switch Opens The Door To Biomolecular Electronics
11. At the molecular level, the predator is the prey
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/21/2017)... PORTLAND, Ore. , Feb. 22, 2017 /PRNewswire/ ... of Companies (Avamere Health Services, Infinity Rehab, Signature Hospice, ... study that will apply the power of IBM cognitive ... and health centers. By analyzing data streaming from sensors ... into physical and environmental conditions, and obtain deeper learnings ...
(Date:2/14/2017)... 2017  Wake Forest Baptist Medical Center today announced Julie ... executive officer (CEO). Freischlag joins the medical center on ... , M.D., who last year announced that he would ... after leading it since 2008.   As ... Forest Baptist,s academic health system, which includes Wake Forest ...
(Date:2/10/2017)... 2017 Research and Markets has ... Medicine - Scientific and Commercial Aspects" to their offering. ... ... integrated with therapy for selection of treatment as well for ... prevention of disease in modern medicine. Biochip/microarray technologies and next ...
Breaking Biology News(10 mins):
(Date:2/22/2017)... ... 2017 , ... ProMIS Neurosciences (“ProMIS” or the “Company”), a ... announced it has issued a scientific white paper entitled “Results from recent Alzheimer’s ... commentaries from ProMIS’s scientific team offering insight into the Company’s product portfolio and ...
(Date:2/22/2017)... Feb. 22, 2017 Aethlon Medical, Inc. (Nasdaq: ... a study that validated the ability of the Aethlon ... with increased mortality in immune-suppressed sepsis patients and also ... The objective of the study was to validate ... Epstein-Barr virus (EBV) and Herpes Simplex virus 1 (HSV1) ...
(Date:2/21/2017)... Synthetic Biologics, Inc. (NYSE MKT: SYN), a ... protect and restore the health of patients, intends to report operational ... on Thursday, March 2, 2017, and to host a conference call ... the call is as follows: U.S. (toll free): 1-888-347-5280 ... ...
(Date:2/21/2017)... , ... February 21, 2017 , ... ... that Dr. Trevor Heritage has joined its executive team to lead the development ... to provide insights to help improve the diagnosis and treatment of cancer. The ...
Breaking Biology Technology: